UAE approves AstraZeneca’s Baxfendy for hypertension
Pharmaceutical Technology
AstraZeneca has received approval from the EDE in the UAE for Baxfendy, a medicine using the active ingredient baxdrostat, for uncontrolled hypertension.
pharminent
May 13, 2026 (Last updated: May 16, 2026)
Pharmaceutical Technology
AstraZeneca has received approval from the EDE in the UAE for Baxfendy, a medicine using the active ingredient baxdrostat, for uncontrolled hypertension.
